Gladstone in the News
March 9, 2022
The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.
Gladstone Experts
COVID-19
Cardiovascular Disease
Data Science and Biotechnology
Virology
Huang Lab
Ott Lab
Pollard Lab
Srivastava Lab
Weinberger Lab
Gladstone in the News
December 15, 2021
abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.
Gladstone Experts
COVID-19
Virology
Weinberger Lab
Gladstone in the News
December 14, 2021
San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.
Gladstone Experts
COVID-19
Center for Cell Circuitry
Virology
Weinberger Lab
Gladstone in the News
October 30, 2020
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts
HIV/AIDS
Center for Cell Circuitry
Virology
Weinberger Lab
Article
June 28, 2020
Leor Weinberger is selected by the National Institute on Drug Abuse for his innovative HIV research
Awards
HIV/AIDS
Weinberger Lab
